Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,653 | Dovepress* | 9,912+ | 1,056 | 10,968 | |
| PubMed Central* | 741 | 269 | 1,010 | ||
| Totals | 10,653 | 1,325 | 11,978 | ||
| *Since 16 October 2017 | |||||
View citations on PubMed Central and Google Scholar